PATENT CLAIM ANALYSIS

Application Number: 15761983
Application Type: Utility
Filing Date: 2018-03
Publication Date: 2018-10
Patent Classification: ["514", "450000"]

Abstract:
There are provided, inter alia, methods and compositions for diagnosis and treatment of acute myeloid leukemia (AML), secondary acute myeloid leukemia (sAML), and age-related diseases.

Claim (Index 85):
The method of  claim 65 , wherein the compound of Formula (I) is selected from the group consisting of:

Metadata:
- Claim Count in Document: 50.0
- Percentile: 90.0
- Lexical Diversity: 1.41667
- Patent Class: 514.0
- Transitional Phrase Type: closed
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['14342384', '12837409', '14236118', '11528890', '13739788']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8072887872289387
- 35 USC 102 Novelty (BERT): 0.5285427775390611
- Combined Prediction Score: 0.7794141862599511
- Mean Citation Score: 266.791298
- Max Citation Score: 290.01474
- Similarity Product: 127.20414800870422

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test